Fundación MEDINA

Casa
España
Granada
Fundación MEDINA

Discovery of new bioactive compounds and innovative therapies
for unmet medical needs and high-value biotechnological products

MEDINA is an independent and non profit Research Organization developing innovative programs, collaborations and contracts with academic and industrial partners worldwide. MEDINA owns one of the largest Microbial Collections and the most chemically diverse Natural Products Libraries

Our team has unique expertise in natural products microbiology, chemistry and high throughput screening, as well as in early preclinical safety, drug metabolism and bioanalysis. We are currently active in drug discovery programs in infectious diseases (including tuberculosis and parasitic diseases),cancer, neurodegeneration, and rare diseases. Leveraging our unique strengths in high resolution-high throughput analytics and bioanalytics we are collaborating with clinical investigators in translational research programs for biomarker discovery and metabolomic profiling of patient samples. We are currently active in drug and biomarker discovery programs in infectious and neglected diseases cancer, CNS, and rare diseases. MEDINA is a Research Organization established in the Health Sciences Technology Park, Granada (Spain) as a private-public partnership between the Government of Andalucía (Spain), the University of Granada and Merck Sharp and Dohme de España S.A.

17/02/2026

🚀 New Article Published! Unlocking the Power of Non GLP Preclinical Studies in Drug Discovery

Before a molecule becomes a drug candidate, it must survive one of the most challenging stages in R&D: preclinical evaluation. And this is where non GLP preclinical studies become true game changers.

In our latest article in Laboratory Animals journal, we highlight how early ADME tox studies—flexible, fast, and cost effective—empower teams to:

✨ Screen more candidates in less time
✨ Identify risks before they become expensive failures
✨ Make smarter go/no go decisions
✨ Select the strongest lead with confidence
✨ Reduce animal use by prioritizing in vitro models

These exploratory studies provide a competitive edge, helping organizations optimize resources while increasing the likelihood of success in later development phases.
Backed by insights from the Preclinical Area at Fundación MEDINA, the article also showcases companies offering ready to use models and on demand assays to accelerate discovery.
If your work touches early drug development, pharmacology, biotech innovation, or strategic R&D decisions… this is a must read.

https://www.medinadiscovery.com/wp-content/uploads/2026/02/Preclinical-Studies-and-GoNo-Go-Decision-Criteria-in-Early-Drug-Development.pdf

👉 Elevate your pipeline. Reduce risk. Accelerate innovation.

-tox SECAL, Sociedad Española para las Ciencias del Animal de Laboratorio Confederación de Sociedades Científicas de España (COSCE) Universidad de Granada MSD España Junta de Andalucía

17/02/2026

Last week our doctoral student Gioele Pecin presented a poster at the “Natural Products in the 21st Century” conference in .

The conference, organised by the students of MAGic-MOLFUN doctoral network, took place at the Provinciehuis Vlaams-Brabant venue in Leuven from 9 to 11 February and welcomed important guests from the field of natural products, offering interesting talks on topics ranging from genomics to metabolomics.

In the poster presented at the conference, Gioele explains how he managed to heterologously express the main genes of the biosynthetic cluster of a new fungal natural product in a black yeast host.

The Novo Nordisk Foundation Center for Biosustainability - DTU Danmarks Tekniske Universitet - DTU Fundación MEDINA Eberhard Karls Universität Tübingen European Union Naicons Newcastle University Wageningen University & Research c-LEcta GmbH

16/02/2026

Hoy se reunían los principales representantes de las ciudades candidatas a albergar la de la Agencia Estatal de Salud Pública en un nuevo debate Imprescindible de GranadaDigital.
En Fundación MEDINA estamos directamente relacionados con la salud publica: nos dedicamos a investigar y desarrollar nuevos fármacos para necesidades médicas o retos en salud pública, como la resistencia a antibióticos.

Apoyamos la candidatura de , nuestra ciudad, para albergar la Sede de la Agencia Estatal de Salud Pública.

Universidad de Granada MSD España Junta de Andalucía

16/02/2026

Excited to participate in the IQF Technical-Scientific Symposium in Madrid, March 10th.
Francisco Castillo, researcher at Fundación MEDINA, will present our latest expertise in combining affinity-based screening with orthogonal cell-free workflows, enabling more efficient drug discovery while tackling challenging targets with confidence. Join us to explore new trends in molecular interactions.

Full agenda and registration: https://nanotempertech.com/events/workshops/iqf-technical-scientific-symposium/
NanoTemper Technologies Instituto de Química Física "Blas Cabrera" (IQF-CSIC) Universidad de Granada MSD España Junta de Andalucía

13/02/2026

Participamos en la “Mesa de la Ciencia y la innovación “del Ayuntamiento de Granada, colaborando en la estrategia e impulso de la e como pilares del desarrollo económico de la ciudad de y su entorno.
Fundación MEDINA Universidad de Granada Junta de Andalucía MSD España

11/02/2026

🌎 Celebrando el presente, inspirando el futuro. 👩‍🔬

En el Día Internacional de la Mujer y la Niña en la Ciencia , queremos dar visibilidad a nuestras científicas desde una perspectiva única: la de quienes mejor las conocen.

🎥 En este vídeo, las hijas y sobrinas de nuestras investigadoras toman la palabra para contarnos qué hacen sus madres y tías en su día a día en el trabajo. Las respuestas muestran como el liderazgo femenino en la ciencia es el mejor ejemplo para las nuevas generaciones.

En FFundación MEDINAno sólo contamos con paridad en nuestra plantilla, sino que la mayoría de los puestos de liderazgo y toma de decisiones están ocupados por mujeres. Nuestras científicas dirigen líneas de investigación, gestionan proyectos internacionales y marcan el rumbo de la innovación en biotecnología. 💪

👧 A todas las niñas con curiosidad: el mundo necesita vuestras preguntas, vuestra visión y vuestro talento. ¡El futuro es vuestro!
Gracias a todas las compañeras de MEDINA por su labor científica y por ser los referentes que la sociedad necesita. 💜
UUniversidad de GranadaJJunta de AndalucíaMSD España

11/02/2026

Last week, we said goodbye to Rabia Nur Ün, a visiting postdoctoral researcher from Ege Üniversitesi, who completed a nine-month secondment at Fundación MEDINA.
She demonstrated great skill and passion for products chemistry.
It was a pleasure working with her!!

10/02/2026

📢 At Fundación MEDINA, as a committed member of the COSCE Agreement for in animal research, we are pleased to share the VIII Annual Transparency Report.

Once again, we reinforce our dedication to clear, responsible, and open communication regarding the use of animals in biomedical research. This year’s report highlights the collective effort of all participating institutions to strengthen transparency practices, promote alternative methods, and raise awareness about the essential role of animal research in advancing scientific and medical progress.

The initiative, led by the Confederación de Sociedades Científicas de España (COSCE) together with the Animal Research Association (EARA), continues to grow and is now a recognized reference across Europe for its impact and commitment to openness.

🔍 Learn more and access the full report below 👇
https://cosce.org/presentacion-del-octavo-informe-anual-del-acuerdo-cosce-por-la-transparencia-en-experimentacion-animal/

Ministerio de Ciencia e Innovación y Universidades Universidad de Granada Junta de Andalucía MSD España en experimentación animal

05/02/2026

You don’t need to be a metabolomics expert. Because we are.

At Fundación MEDINA, we help academic groups, biotech innovators, and pharma teams unlock the metabolomic signature in their samples. And we go far beyond the standard service:

1️⃣ We Analyze What Others Can’t
We work with a wide range of challenging and unconventional sample types, going well beyond the typical matrices. Our expertise means fewer limitations and more discovery.

2️⃣ Don’t Get Lost in the Data
Metabolomics generates complexity. We deliver clarity. Our team provides full biological interpretation, turning mass spec outputs into actionable insights that advance your study.

3️⃣ Fast-Track Your Results
Scientific rigor meets operational efficiency. You get robust data, exactly when you need it.

🚀 Ready to accelerate your research?

Send us a message to talk about how our metabolomics platform and expertise in metabolomics for biomarker discovery in human samples can support your next project.
https://www.medinadiscovery.com
de Granada de Andalucía España

27/01/2026

Fundación MEDINA at the ACI Biopesticides Europe 2026! 🚀

Don’t miss this opportunity to attend the conference "Harnessing the Potential of Natural Products for the discovery of new biopesticides " by Victor Gonzalez Menendez, PhD, Principal Scientist in Microbiology and Fungal Collection Manager at Fundación MEDINA.

📍 See you on June 10–11 in , The .
Universidad de Granada Junta de Andalucía MSD España

23/01/2026

📍 Fundación MEDINA hosted the 25M meeting of the PROSPLIGN consortium on January 20–21.

It was a great opportunity to bring partners together, review progress, align on next steps, and continue strengthening collaboration toward our shared goals.
Thank you to all consortium members, KelAda Pharmachem, University of Helsinki , Universidade Nova de Lisboa , University College Dublin , Magfi and the BFH-HAFL for the productive discussions, engagement, and continued commitment — we’re looking forward to the next milestones ahead.
European Research Executive Agency (REA)

19/01/2026

Biotecnología de Productos Naturales contra el mosquito: Ecopest III

En esta fase definitiva, materializamos soluciones de baja huella ambiental y alta eficacia. Tras validar su seguridad e impacto in vitro e in vivo (Aedes albopictus), nuestros biopesticidas evolucionan:

🔹 Máxima Potencia: Enriquecemos las fórmulas mediante la identificación y concentración de los productos naturales bioactivos.
🔹 Amplio Espectro: Desarrollamos aerosoles y cebos eficaces frente a múltiples especies (Culex).
🔹 Sostenibilidad: Soluciones de origen biológico (TRL 4-6) sin uso de piretroides.

Transformamos ciencia de vanguardia en entornos urbanos más sanos. 🌿🔬

Iniciativa financiada por el Ministerio de Industria y Turismo dentro del programa de apoyo a las AEI para contribuir a la mejora de la competitividad de las pequeñas y medianas empresas.
Referencia: AEI-010500-2025-11

Universidad de Granada Junta de Andalucía MSD España
Medio Ambiente intelligenia Fundación MEDINA OnTech Innovation

Dirección

Parque Tecnológico De La Salud/Avenida Del Conocimiento, 34
Granada
18016

Página web

http://www.medinadiscovery.com/

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Fundación MEDINA publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.